Cinnamaldehyde accelerates wound healing by promoting angiogenesis via up-regulation of PI3K and MAPK signaling pathways
Autor: | Liwen Han, Momoko Ishii, Xing Yuan, Kechun Liu, Weidong Zhang, Wanlin Chang, Peng Fu, Chao Lv, Tai-Ping Fan, Lin Han, R Scott Runyon, Run-Hui Liu, Hua-Wu Zeng |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Male Vascular Endothelial Growth Factor A Nitric Oxide Synthase Type III Angiogenesis MAP Kinase Signaling System Pyridines Neovascularization Physiologic Pharmacology Pathology and Forensic Medicine Neovascularization 03 medical and health sciences chemistry.chemical_compound Mice 0302 clinical medicine Cassia Cell Movement medicine Human Umbilical Vein Endothelial Cells Animals Humans Therapeutic angiogenesis Acrolein Molecular Biology Protein kinase B Cells Cultured Zebrafish Cell Proliferation Tube formation Wound Healing biology Chemistry Cell Biology biology.organism_classification Up-Regulation Vascular endothelial growth factor Mice Inbred C57BL 030104 developmental biology 030220 oncology & carcinogenesis Phthalazines medicine.symptom Phosphatidylinositol 3-Kinase Wound healing |
Zdroj: | Laboratory investigation; a journal of technical methods and pathology. 98(6) |
ISSN: | 1530-0307 |
Popis: | The bark of Cinnamomum cassia (C. cassia) has been used for the management of coronary heart disease (CHD) and diabetes mellitus. C. cassia may target the vasculature, as it stimulates angiogenesis, promotes blood circulation and wound healing. However, the active components and working mechanisms of C. cassia are not fully elucidated. The Shexiang Baoxin pill (SBP), which consists of seven medicinal materials, including C. cassia etc., is widely used as a traditional Chinese patent medicine for the treatment of CHD. Here, 22 single effective components of SBP were evaluated against the human umbilical vein endothelial cells (HUVECs). We demonstrated that in HUVECs, cinnamaldehyde (CA) stimulated proliferation, migration, and tube formation. CA also activated the phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways. Furthermore, the secretion of vascular endothelial growth factor (VEGF) from HUVECs was increased by CA. In vivo, CA partially restored intersegmental vessels in zebrafish pretreated with PTK787, which is a selective inhibitor for vascular endothelial growth factor receptor (VEGFR). CA also showed pro-angiogenic efficacy in the Matrigel plug assay. Additionally, CA attenuated wound sizes in a cutaneous wound model, and elevated VEGF protein and CD31-positive vascular density at the margin of these wounds. These results illustrate that CA accelerates wound healing by inducing angiogenesis in the wound area. The potential mechanism involves activation of the PI3K/AKT and MAPK signaling pathways. Such a small non-peptide molecule may have clinical applications for promoting therapeutic angiogenesis in chronic diabetic wounds and myocardial infarction. |
Databáze: | OpenAIRE |
Externí odkaz: |